These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6165484)

  • 1. Modulation of adoptive cell transfers in experimental allergic encephalomyelitis by antigen treatment of donors.
    Rauch HC
    Cell Immunol; 1981 May; 60(1):220-7. PubMed ID: 6165484
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfer of experimental allergic encephalomyelitis with guinea pig peritoneal exudate cells.
    Driscoll BF; Kies MW; Alvord EC
    Science; 1979 Feb; 203(4380):547-8. PubMed ID: 83676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of experimental allergic encephalomyelitis in the Lewis rat with activated spleen cells: differential activation with mitogens.
    Peters BA; Hinrichs DJ
    Cell Immunol; 1982 May; 69(1):175-85. PubMed ID: 6179635
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active disease in the donor.
    Cross AH; Raine CS
    J Neuroimmunol; 1990 Jun; 28(1):27-37. PubMed ID: 1692846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of continuous antigenic stimulation by the locally retained antigens in chronic relapsing experimental allergic encephalomyelitis.
    Tabira T; Itoyama Y; Kuroiwa Y
    J Neurol Sci; 1984 Oct; 66(1):97-106. PubMed ID: 6084050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic encephalomyelitis: modification of the response by synthetic membrane structures containing bovine myelin basic protein and cerebroside.
    Brostoff SW; Powers JM
    Brain Res; 1975 Jul; 93(1):175-81. PubMed ID: 49214
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis.
    Swanborg RH
    Methods Enzymol; 1988; 162():413-21. PubMed ID: 2465480
    [No Abstract]   [Full Text] [Related]  

  • 9. Adoptive transfer of experimental allergic encephalomyelitis (EAE): prevention of successful transfer by treatment of donors with myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1975 Jan; 114(1 Pt 2):291-2. PubMed ID: 46879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of cytotoxicity with experimental allergic encephalomyelitis.
    Allbritton AR; Loan RW
    Cell Immunol; 1975 Sep; 19(1):91-8. PubMed ID: 52410
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis: clinical disease and enhanced cellular transfer in the absence of lymphocyte proliferative responses against syngeneic MBP.
    Hunter S
    Cell Immunol; 1986 Jan; 97(1):204-9. PubMed ID: 2427218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A suppressor cell line that prevents the adoptive transfer of EAE in Lewis rats.
    Ellerman K; Brostoff S
    Ann N Y Acad Sci; 1988; 540():364-6. PubMed ID: 2462813
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of acute experimental allergic encephalomyelitis in mice by colchicine.
    Lyons MJ; Amador R; Petito C; Nagashima K; Weinreb H; Zabriskie JB
    J Exp Med; 1986 Nov; 164(5):1803-8. PubMed ID: 2430048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of autoimmune encephalomyelitis with T lymphocytes in strain 13 guinea pigs.
    Jarjour WN; Asofsky R; Raine CS; Stone SH
    Cell Immunol; 1986 Dec; 103(2):462-8. PubMed ID: 2433054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
    Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
    Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoptive transfer of experimental allergic encephalomyelitis from immature guinea pig donors.
    Stone SH; Snyder DH; Raine CS
    J Neurol Sci; 1983; 60(3):401-9. PubMed ID: 6631443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1969 Dec; 103(6):1248-53. PubMed ID: 5361563
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.
    Swierkosz JE; Swanborg RH
    J Immunol; 1975 Sep; 115(3):631-3. PubMed ID: 50370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-encephalitogenic antigen-induced suppression and reversal of allergic encephalomyelitis.
    Hashim GA
    Nature; 1975 Aug; 256(5518):953-5. PubMed ID: 52118
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A.
    Panitch HS; McFarlin DE
    J Immunol; 1977 Sep; 119(3):1134-7. PubMed ID: 302272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.